Stock-Based Compensation (Narrative) (Details)					1 Months Ended	12 Months Ended
	Apr. 29, 2024 USD ($) employee milestone	Feb. 24, 2024 USD ($) milestone	Oct. 04, 2022 USD ($) shares	Dec. 01, 2021 USD ($) milestone	Feb. 29, 2024 USD ($) milestone	Dec. 31, 2024 USD ($) milestone shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)	Dec. 31, 2016 tranche $ / shares	Dec. 31, 2021 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						3 years
Granted (in shares) | shares						29,235,000
Stock-based compensation expense						$ 18,457,000	$ 23,504,000	$ 42,415,000
Other liabilities, noncurrent						25,001,000	33,400,000
Aggregate intrinsic value						$ 0	$ 0	0		$ 3,500,000
Stock options exercisable (in shares) | shares						0	0
Unrecognized stock-based compensation expense						$ 0	$ 0
Stock based compensation expense reversal							$ 18,400,000
Diluted (in dollars per share) | $ / shares							$ 0.14
Basic (in dollars per share) | $ / shares							$ 0.14
Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage						33.33%
Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage						33.33%
Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage						33.33%
Volumetric Biotechnologies, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 0	$ (8,600,000)	8,000,000.0
Additional payments	$ 175,000,000			$ 355,000,000.0	$ 355,000,000
Number of milestones | milestone				7
Milestones terminated | milestone		4			4
Reduced liability		$ 175,000,000.0			$ 175,000,000
Remaining milestones | milestone	3	3			3
Number of employees | employee	2
Earnout payment milestone							65,000,000
Aggregate grant date fair value of outstanding and unvested							4,500,000
Volumetric Biotechnologies, Inc. | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of milestones | milestone					4
Volumetric Biotechnologies, Inc. | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of milestones | milestone					7
Dp polar GmbH
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 1,000,000.0	$ 1,000,000.0	300,000
Additional payments			$ 2,200,000
Issuance of shares (in shares) | shares			250,000
Systemic Bio Phantom Unit Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Units outstanding (in shares) | shares						721,000	596,000
Phantom Share Units (PSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						1 year 10 months 24 days
Unrecognized stock-based compensation expense						$ 19,200,000
Phantom Share Units (PSUs) | Systemic Bio Phantom Unit Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						4 years
Granted (in shares) | shares						147,000	597,000
Stock-based compensation expense						$ 100,000	$ 500,000
Other liabilities, noncurrent						$ 600,000	500,000
Restricted Stock - Market Conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares awarded (in shares) | shares						1,435,000
Stock Options and Restricted Stock Awards | 2015 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of tranches | tranche									2
Trading price for stock award, tranche one (in dollars per share) | $ / shares									$ 30
Trading price for stock award, tranche two (in dollars per share) | $ / shares									$ 40
Stock award tranche granting period									90 days
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of non-financial milestones | milestone						4
Incentive Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 0	$ 0	$ 4,000,000.0